Login
Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

InnovAge Holding Corp. INNV

Healthcare — Medical Care Facilities

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Register an account and get your Powerpack now or Login

Insider Decisions

Total sells
0.16
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — 1 — — — — — — — — — —
Insider Ownership
84.32%

Capital & Financial Ratios

Market Cap
1,460.00
Revenue
989.71
Net Income
(0.68)
Free Cash Flow
54.12
Net Debt
(85.03)
Current Ratio
1.05
Debt/Equity
0.24
P/E ratio
0.00
P/S ratio
1.50
P/B ratio
6.21
Past 5Y EPS Growth
—
This Y EPS Growth
2,301.71%
Next Y EPS Growth
13.42%
Next 5Y EPS Growth
—
in millions of $

Dividends

Payout Ratio
0.00
Annual Dividend Rate
—
Annual Dividend Yield
—
total individual payouts
2025 ‡‡‡
2024 ‡‡‡
2023 ‡‡‡
2022 ‡‡‡
2021 ‡‡‡
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 2026
Cash 173.48 102.79 105.92 141.34
Receivables 24.61 51.43 39.68 45.67
Inventory — — — —
Other 17.15 — 6.04 —
215.23 173.14 176.11 214.31
2023 2024 2025 2026
Payables 54.94 55.46 76.75 115.36
ST’ Debt 3.80 3.80 2.25 2.54
Other 52.14 70.60 75.89 75.13
148.45 138.60 164.81 203.89
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — ‡‡‡‡‡ ‡‡‡‡‡
Cash Flow — ‡‡‡ ‡‡‡‡‡
Earnings — ‡‡‡ ‡‡‡
Book Value — ‡‡‡‡‡ ‡‡‡‡‡

Revenue

Sep Dec Mar Jun Year
’26 — — — —
—
’26 236.11 239.71 251.94 261.95
989.71
’25 205.14 209.00 218.14 221.42
853.70
’24 182.49 188.90 193.07 199.40
763.86
’23 171.22 167.46 172.54 176.87
688.09
’22 173.07 175.35 177.36 172.86
698.64
’21 152.57 157.31 156.31 171.62
637.80
in millions of $

Operating Cash Flow

Sep Dec Mar Jun Year
’26 — — — —
—
’26 3.92 21.36 18.14 21.29
64.71
’25 (7.52) 6.75 24.63 9.00
32.87
’24 (32.98) (9.29) 3.51 1.87
(36.90)
’23 13.13 (35.12) 29.08 13.15
20.24
’22 20.56 11.02 (7.52) 3.24
27.30
’21 (18.06) 17.32 (16.28) 9.48
(7.55)
in millions of $

Free Cash Flow

Sep Dec Mar Jun Year
’26 — — — —
—
’26 (0.15) 19.00 18.25 17.02
54.12
’25 (9.72) 5.41 21.73 9.18
26.60
’24 (35.56) (10.88) 3.06 (1.43)
(44.81)
’23 5.46 (42.08) 24.38 9.13
(3.12)
’22 17.52 2.38 (17.41) (14.85)
(10.94)
’21 (22.69) 8.48 (18.90) 6.02
(27.09)
in millions of $

EPS

Sep Dec Mar Jun Year
’26 — — — —
—
’26 0.06 0.08 (0.22) 0.06
(0.02)
’25 (0.04) (0.10) (0.08) (0.01)
(0.22)
’24 (0.08) (0.03) (0.04) (0.01)
(0.16)
’23 (0.10) (0.07) (0.05) (0.09)
(0.30)
’22 0.06 0.01 (0.02) (0.09)
(0.05)
’21 (0.37) 0.07 (0.09) 0.05
(0.36)

Target Price Range

High
‡‡‡‡‡
‡‡‡‡
Average
‡‡‡‡‡
‡‡‡‡
Low
‡‡‡‡‡
‡‡‡‡

Recommendation Rating

3
1
Buy
2
3
Hold
4
5
Sell
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029
— — — — ‡‡‡‡ 3.39 5.04 3.52 2.60 5.16 — — —
Low Price
— — — — ‡‡‡‡‡ 7.85 8.15 6.69 6.26 12.64 — — —
High Price
— — — ‡‡‡‡‡ ‡‡‡‡‡ 2,000 2,100 2,350 2,440 2,500 — — —
Employees
— — ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.35 0.33 0.33 0.35 0.40 — — —
Revenue/Emp
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 698.64 688.09 763.86 853.70 989.71 ‡‡‡‡‡ ‡‡‡‡‡ —
Revenue
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 19.38% 14.72% 17.29% 18.00% 23.01% — — —
Gross Margin
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (7.24) (50.79) (21.82) (34.03) 0.27 — — —
EBT
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (1.04%) (7.38%) (2.86%) (3.99%) 0.03% ‡‡‡ ‡‡‡ —
EBT Margin
‡‡‡ — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (7.96) (43.55) (23.22) (35.34) (0.68) ‡‡‡‡‡ ‡‡‡‡‡ —
Net Income
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 14.35 15.85 19.38 19.94 21.91 — — —
Depreciation
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 5.16 5.07 5.62 6.31 7.29 ‡‡‡‡‡ ‡‡‡‡‡ —
Revenue/Sh
— — ‡‡‡‡ ‡‡‡ ‡‡‡‡‡ (0.05) (0.30) (0.16) (0.22) (0.02) ‡‡‡‡‡ ‡‡‡‡‡ —
Earnings/Sh
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.20 0.15 (0.27) 0.24 0.48 — — —
Cash Flow/Sh
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (0.28) (0.17) (0.06) (0.05) (0.08) ‡‡‡ ‡‡‡ —
Capex/Sh
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (0.08) (0.02) (0.33) 0.20 0.40 — — —
Free CF/Sh
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2.50 2.23 2.04 1.76 1.76 — — —
Book Value/Sh
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 135.52 135.59 135.90 135.39 135.70 ‡‡‡‡‡ ‡‡‡‡‡ —
Shares
— — ‡‡‡ ‡‡‡ ‡‡‡ 0.00 0.00 0.00 0.00 0.00 ‡‡‡‡ ‡‡‡‡ —
PE Ratio
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.85 1.48 0.90 0.59 1.62 ‡‡‡ ‡‡‡ —
PS Ratio
— — ‡‡‡ ‡‡‡ ‡‡‡‡‡ 1.75 3.37 2.47 2.10 6.73 ‡‡‡ ‡‡‡ —
PB Ratio
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.70 1.34 0.86 0.54 1.54 ‡‡‡‡ ‡‡‡‡ —
EV/Sales
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (34.13) (141.15) (13.68) 19.90 30.05 — — —
EV/FCF
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 27.30 20.24 (36.90) 32.87 64.71 ‡‡‡ ‡‡‡ —
Op' Cash Flow
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (38.24) (23.35) (7.91) (6.26) (10.59) ‡‡‡‡‡ — —
Capex
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (10.94) (3.12) (44.81) 26.60 54.12 — — —
FCF
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 135.65 66.78 34.54 11.30 10.42 — — —
Working Cap'
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 81.44 81.75 78.02 67.25 56.31 — — —
Total Debt
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (103.00) (91.72) (24.78) (38.67) (85.03) — — —
Net Debt
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 338.47 302.09 277.61 237.90 238.76 — — —
Sh' Equity
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (1.20%) (7.24%) (3.83%) (5.64%) (0.47%) — — —
ROA
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (1.17%) (14.68%) (5.73%) (9.34%) 1.06% — — —
ROIC
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (1.92%) (12.70%) (7.36%) (11.76%) (1.06%) — — —
ROE
predictions in italic, sparklines do not include predictions

Analyst Commentary (Summary)

InnovAge Holding Corp. (INNV), a key player in Program of All-Inclusive Care for the Elderly (PACE) services for frail seniors, has powered through operational headwinds with resilient revenue growth, compounding at 10.6% annually from $466 million in 2019 to $854 million in 2025, and projected to hit $1.11 billion by 2028. Despite gross margin erosion from a 2021 peak of 27.3% to 14.7% in 2023—hit by healthcare cost inflation and regulatory scrutiny—the stock trades at a striking premium, 16% above the highest analyst target as of February 2026. Insider buying in mid-2025, including key executives snapping up shares at depressed prices, underscores confidence in a sharp profitability rebound amid post-IPO volatility recovery.

A fortified balance sheet—debt slashed 65% to a net cash position—and forecasts of EBT flipping positive to $31 million in 2026 (3.3% margin), with EPS surging to $0.56 by 2028, paint an optimistic turnaround. Valuations look compelling at 0.59x PS and forward multiples far below peers, with DCF models hinting at 15-25% upside if execution delivers on center expansions and cost controls. Yet risks like reimbursement cuts and labor shortages loom—will INNV capitalize on its scalability in the underserved senior care market?

Read full commentary →

InnovAge Holding Corp. (INNV) Latest News

News by impact score

Fine-tune

10 Sep

3 , 8:11 PM
InnovAge (INNV) posts 9.6% adjusted EBITDA margin with PACE recovery progress whose durability remains in question. Margin gain lifts near-term profitability metrics while PACE sustainability questions cap broader valuation shifts.

9 Sep

4 transcript www.fool.com, 6:43 PM
InnovAge (INNV) Q4 2026 earnings call transcript covers financial results, operational updates and management commentary. Earnings call reveals year-end results and guidance that can shift investor sentiment and valuation.

4 , 1:00 AM
InnovAge Holding Corp posted strong EBITDA growth in Q4 2026 earnings call highlights. Strong EBITDA growth directly improves financial metrics and lifts stock valuation.

3 transcript app.moby.co, 8:30 AM
InnovAge Holding Corp. Q4 2026 earnings call outlined financial results, operational metrics and forward guidance. Quarterly earnings data supplies performance benchmarks that can shift near-term valuation without altering core strategy.

8 Sep

3 transcript www.marketbeat.com, 7:03 PM
INNV Q4 earnings call highlighted financial results, operational updates and future outlook for InnovAge Holding Corp. Q4 earnings details may affect short-term investor sentiment and stock performance without major strategic shifts.

3 , 4:05 PM
InnovAge Holding Corp. (INNV) released financial results for the fourth quarter and fiscal year ended June 30, 2026. Quarterly and annual financial results provide performance data that can shift near-term investor sentiment and valuation.

13 May

3 Simply Wall St., 7:12 PM
InnovAge Holding Corp. (INNV) shares dropped 9.0% after raising 2026 revenue guidance, as a wider quarterly loss overshadowed the positive long-term outlook. Raised 2026 revenue guidance boosts long-term growth expectations while wider loss triggers short-term negative market reaction.

12 May

4 GlobeNewswire, 4:30 PM
InnovAge Holding Corp. (INNV) appoints Jennifer Browne as President and Chief Operating Officer. Appointment of a new President and COO constitutes a major leadership change likely to influence operational strategy and investor sentiment.

6 May

4 app.moby.co, 8:30 AM
InnovAge Holding Corp. released Q3 2026 earnings call summary detailing financial results, operational updates, and forward guidance. Q3 2026 earnings call summary discloses financial performance and strategic guidance likely to significantly sway investor sentiment and market trajectory.

5 May

4 www.marketbeat.com, 8:38 PM
InnovAge Holding Corp. (INNV) Q3 earnings call highlights financial results, operational metrics, and forward-looking guidance. Q3 earnings call highlights disclose financial performance and guidance that significantly shape investor sentiment and stock trajectory.

4 GlobeNewswire, 4:05 PM
InnovAge Holding Corp. (INNV) announced financial results for its fiscal third quarter ended March 31, 2026. Quarterly earnings releases typically drive significant stock volatility and shape future market performance expectations.

3 Zacks, 6:05 PM
InnovAge Holding Corp. (INNV) reported a Q3 net loss but beat revenue estimates. Q3 loss despite revenue beat influences financial performance and investor sentiment moderately.

4 May

3 Zacks, 8:54 AM
InnovAge Holding Corp. (INNV) anticipates robust growth to counter seasonal margin pressures in Q3 earnings. Growth prospects may offset seasonal margin declines, moderately impacting Q3 earnings performance.

9 Apr

4 Zacks, 11:56 AM
Humana invests in pharmacists to improve chronic care outcomes through InnovAge Holding Corp., enhancing patient management and efficiency in senior care programs. Humana's strategic emphasis on pharmacists strengthens InnovAge's competitive edge in chronic care delivery.

15 Mar

4 Simply Wall St., 10:08 PM
InnovAge (INNV) earnings optimism prompts questions on whether it signals a deeper shift in the company's turnaround narrative. Earnings optimism highlights potential strategic turnaround progress, significantly influencing INNV's trajectory and investor sentiment.

13 Mar

4 Zacks, 12:00 PM
Analysts upgraded InnovAge Holding Corp. (INNV) to a Strong Buy rating, citing improved operational metrics, revenue growth, and positive market positioning in the PACE sector. Strong Buy upgrade signals major positive shift in analyst outlook, likely driving investor interest and stock price gains.

26 Feb

3 Zacks, 12:20 PM
Analysts are raising earnings estimates for InnovAge Holding Corp. (INNV), signaling potential improved financial performance and prompting consideration as a buy opportunity. Rising earnings estimates indicate moderately improved financial expectations, likely boosting short-term investor sentiment without fundamentally altering long-term trajectory.

6 Feb

4 transcript GuruFocus.com, 6:01 PM
InnovAge Holding Corp. (INNV) reported strong revenue growth in its Q2 2026 earnings call, highlighting significant increases in key financial metrics. The company emphasized its strategic initiatives aimed at enhancing service delivery and expanding its market presence. Management expressed optimism about future performance, citing positive trends in customer acquisition and retention. Overall, the earnings call reflected a robust outlook for InnovAge as it navigates the competitive landscape. Strong revenue growth and strategic initiatives indicate significant potential for future performance and market positioning.

3 Simply Wall St., 5:07 AM
InnovAge Holding Corp. (INNV) has experienced significant share price volatility recently, prompting a reassessment of its valuation. Analysts are evaluating the factors contributing to this fluctuation, including market conditions and company performance metrics. The analysis aims to provide insights into the potential future trajectory of InnovAge, considering both risks and opportunities in the current healthcare landscape. Recent share price volatility indicates a moderately noticeable influence on InnovAge's market performance and investor sentiment.

5 Feb

4 Zacks, 12:00 PM
InnovAge Holding Corp. (INNV) has been upgraded to a Strong Buy rating by analysts, indicating a positive outlook for the company's stock. This upgrade reflects confidence in InnovAge's business model and growth potential, suggesting that investors may see significant returns in the near future. The upgrade is expected to influence market sentiment and could lead to increased investor interest in the stock. The upgrade to Strong Buy indicates significant positive sentiment and potential for improved market performance.

4 , 8:45 AM
InnovAge Holding Corp. showcased its proven senior care model at a Capitol event, emphasizing the importance of innovative care solutions for the aging population. The presentation highlighted the company's commitment to enhancing the quality of life for seniors through personalized care and support services. Lawmakers and stakeholders were engaged in discussions about the future of senior care and the role of organizations like InnovAge in addressing the growing needs of this demographic. The event's focus on senior care solutions aligns with significant regulatory and market dynamics that could enhance InnovAge's strategic positioning.

4 Feb

4 transcript GuruFocus.com, 12:00 AM
InnovAge Holding Corp. (INNV) reported strong revenue growth in its Q2 2026 earnings call, highlighting significant increases in patient enrollment and service utilization. The company emphasized its commitment to expanding its market presence and improving operational efficiencies. Despite challenges in the healthcare sector, InnovAge remains optimistic about future growth prospects and strategic initiatives aimed at enhancing patient care and satisfaction. Strong revenue growth and strategic initiatives indicate a significant impact on future performance and market positioning.

3 Feb

4 Zacks, 5:15 PM
InnovAge Holding Corp. (INNV) reported Q2 earnings and revenues that exceeded analysts' expectations, showcasing strong financial performance. The company highlighted growth in its senior care services, driven by increased enrollment and operational efficiencies. Management expressed optimism about future prospects, citing strategic initiatives aimed at expanding their market presence and enhancing service delivery. Overall, the results reflect a positive trajectory for InnovAge in a competitive healthcare landscape. Strong earnings and revenue growth indicate significant positive momentum and potential for future expansion.

3 www.marketbeat.com, 7:07 PM
InnovAge Holding Corp. reported its Q2 earnings, highlighting key financial metrics and operational updates. The company experienced growth in its membership base and revenue, driven by increased demand for its services. Management discussed strategic initiatives aimed at enhancing care delivery and expanding market presence. Challenges related to regulatory compliance and operational efficiency were also addressed, with plans in place to mitigate these issues moving forward. Growth in membership and revenue indicates a moderately positive influence on financial performance.

3 GlobeNewswire, 4:05 PM
InnovAge Holding Corp. reported its financial results for the fiscal second quarter ended December 31, 2025, highlighting key metrics such as revenue growth and operational performance. The company continues to focus on expanding its services and improving patient care, which contributed to its positive financial outcomes. Management expressed optimism about future growth prospects and strategic initiatives aimed at enhancing market position. The financial results indicate moderate growth and operational improvements, which may influence investor sentiment and market positioning.

29 Jan

3 GlobeNewswire, 8:00 AM
InnovAge Holding Corp. has expanded its board of directors with the appointment of two new members, enhancing its governance and strategic oversight. The new directors bring extensive experience in healthcare and business management, which is expected to support InnovAge's growth and operational objectives. The addition of experienced directors may positively influence the company's strategic direction and operational effectiveness.

26 Jan

3 Simply Wall St., 6:27 AM
InnovAge Holding Corp. is facing challenges as its returns on capital are not reflecting positively on the business. The company's performance metrics indicate inefficiencies that could hinder future growth and investor confidence. Analysts are concerned about the sustainability of its operations and the potential impact on market positioning. Returns on capital not meeting expectations may moderately influence financial performance and investor sentiment.

14 Jan

3 Zacks, 2:04 PM
Options traders are showing increased activity in InnovAge Holding Corp. (INNV), indicating a potential expectation of significant price movement in the stock. The heightened trading volume in options suggests that investors are positioning themselves for volatility, which could be driven by upcoming earnings reports or other market events. Analysts are closely monitoring these developments as they may signal shifts in investor sentiment and market dynamics surrounding the company. Increased options trading activity may influence market sentiment and investor positioning, but the overall effect on the company's trajectory is expected to be limited.

16 Dec

3 Zacks, 7:36 AM
InnovAge Holding Corp. (INNV) experienced a 7.8% increase in stock price, raising questions about the sustainability of this upward trend. Analysts are evaluating the factors contributing to this rise and whether it reflects a lasting improvement in the company's market position or is merely a short-term fluctuation. The stock price increase indicates a moderately noticeable influence on market sentiment and potential financial performance.

11 Nov

4 GlobeNewswireHospital ManagementGuruFocus.comZacksHospital ManagementGuruFocus.com, 3:00 PM
InnovAge Holding Corp. and Tampa General Hospital have celebrated their partnership in senior care with a grand re-opening event. This collaboration aims to enhance healthcare services for seniors, focusing on comprehensive care and support. The partnership is expected to improve access to quality healthcare for the aging population in the Tampa area, aligning with InnovAge's mission to provide specialized care for seniors. The partnership with Tampa General Hospital is a significant strategic move that could enhance InnovAge's service offerings and market position in senior care.
© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us